Funding news
Cambridge Nutraceuticals logo

Cambridge Nutraceuticals Secures $100K

Recently funded · $100.0K UnknownHospitals and Health CareGBView source

Get the full Cambridge Nutraceuticals company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Cambridge Nutraceuticals, the Cambridge-based supplement maker focused on clinically tested and easy-to-absorb products, has secured $100K in new investment. The company, founded in 2012, develops supplements like ATERONON HEART+, which saw £12 million in research funding and clinical testing at Cambridge University Hospital NHS Foundation Trust. Its popular TURMERIC+ joint health supplement is now supported by 41 published studies.

The firm sells direct-to-customer in the UK and reaches international purchasers through overseas distributors, with Australia noted as an important market.

Other United Kingdom companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Hana logo

Hana

United States

$100.0K
2
exnaton logo

exnaton

Switzerland

$100.0K
3
TechAI logo

TechAI

India

$100.0K
4
LinkedIn logo

LinkedIn

United States

$100.0K
5
Radiance Space Solutions Pvt. Ltd. logo

Radiance Space Solutions Pvt. Ltd.

India

$100.0K